Jump Financial, LLC Fennec Pharmaceuticals Inc. Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$8.82 - $11.12 $43,218 - $54,487	4,900 Added 34.75%	19,000 $211,000
Q4 2023 Oct 21, 2024	SELL	$6.48 - $11.61 $777 - $1,393	-120 Reduced 0.84%	14,100 $158,000
Q4 2023 Feb 07, 2024	BUY	$6.48 - $11.61 $91,368 - $163,701	14,100 New	14,100 $158,000
Q1 2023 Oct 21, 2024	BUY	$7.38 - $10.35 $104,943 - $147,177	14,220 New	14,220 $118,000
Q1 2023 May 03, 2023	SELL	$7.38 - $10.35 $49,969 - $70,079	-6,771 Reduced 32.26%	14,220 $118,000
Q4 2022 Feb 13, 2023	BUY	$7.63 - $10.22 $160,161 - $214,528	20,991 New	20,991 $201,000

14.7M

10K

83.8K

Ticker FENC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,067,300
Market Cap $170M
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.